Fox Run Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$999K Buy
37,705
+4,274
+13% +$113K 0.17% 191
2025
Q1
$807K Buy
+33,431
New +$807K 0.13% 278
2022
Q1
Sell
-11,199
Closed -$52K 715
2021
Q4
$52K Buy
+11,199
New +$52K 0.03% 439
2019
Q1
Sell
-10,926
Closed -$84K 706
2018
Q4
$84K Buy
+10,926
New +$84K 0.04% 472